Similarly, among the Crohn's cohort, the low dose achieved an endoscopic remission in 26.1% of patients, versus 13% with placebo, rising to 47.8% with the high dose and 34.8% for the matched control.
Preview: Al Ittihad vs. Al Shabab - prediction, team news, lineups Preview: Australian Open: Ben Shelton vs Lorenzo Sonego - prediction, head-to-head, tournament so f... Preview: USA vs. Costa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback